US BANCORP \DE\ - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$22,000
+214.3%
3,989
+179.7%
0.00%
Q2 2022$7,000
-70.8%
1,426
-55.8%
0.00%
Q1 2022$24,000
+33.3%
3,229
+17.1%
0.00%
Q4 2021$18,000
+38.5%
2,758
+30.6%
0.00%
Q3 2021$13,000
+8.3%
2,112
+80.4%
0.00%
Q2 2021$12,000
+500.0%
1,171
+561.6%
0.00%
Q1 2021$2,0000.0%177
+22.9%
0.00%
Q4 2020$2,0000.0%1440.0%0.00%
Q3 2020$2,000
-33.3%
1440.0%0.00%
Q2 2020$3,000
-25.0%
144
-26.2%
0.00%
Q1 2020$4,0000.0%1950.0%0.00%
Q4 2019$4,000
+100.0%
1950.0%0.00%
Q3 2019$2,000
-92.0%
195
-95.4%
0.00%
Q2 2019$25,000
+4.2%
4,230
+4.8%
0.00%
Q1 2019$24,000
+242.9%
4,035
+467.5%
0.00%
Q4 2018$7,000
-78.8%
711
+1.6%
0.00%
Q2 2014$33,000
+57.1%
700
+2.2%
0.00%
Q1 2014$21,000
-27.6%
685
-46.3%
0.00%
Q4 2013$29,0001,2760.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders